Literature DB >> 24836582

Non-stoichiometric O-acetylation of Shigella flexneri 2a O-specific polysaccharide: synthesis and antigenicity.

Charles Gauthier1, Pierre Chassagne, François-Xavier Theillet, Catherine Guerreiro, Françoise Thouron, Farida Nato, Muriel Delepierre, Philippe J Sansonetti, Armelle Phalipon, Laurence A Mulard.   

Abstract

Synthetic functional mimics of the O-antigen from Shigella flexneri 2a are seen as promising vaccine components against endemic shigellosis. Herein, the influence of the polysaccharide non-stoichiometric di-O-acetylation on antigenicity is addressed for the first time. Three decasaccharides, representing relevant internal mono- and di-O-acetylation profiles of the O-antigen, were synthesized from a pivotal protected decasaccharide designed to tailor late stage site-selective O-acetylation. The latter was obtained via a convergent route involving the imidate glycosylation chemistry. Binding studies to five protective mIgGs showed that none of the acetates adds significantly to broad antibody recognition. Yet, one of the five antibodies had a unique pattern of binding. With IC50 in the micromolar to submicromolar range mIgG F22-4 exemplifies a remarkable tight binding antibody against diversely O-acetylated and non-O-acetylated fragments of a neutral polysaccharide of medical importance.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24836582     DOI: 10.1039/c3ob42586j

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  10 in total

1.  Influence of Shigella flexneri 2a O Antigen Acetylation on Its Bacteriophage Sf6 Receptor Activity and Bacterial Interaction with Human Cells.

Authors:  Min Yan Teh; Axel Furevi; Göran Widmalm; Renato Morona
Journal:  J Bacteriol       Date:  2020-11-19       Impact factor: 3.490

2.  Conformational and Immunogenicity Studies of the Shigella flexneri Serogroup 6 O-Antigen: The Effect of O-Acetylation.

Authors:  Nicole Inge Richardson; Neil Ravenscroft; Vanessa Arato; Davide Oldrini; Francesca Micoli; Michelle M Kuttel
Journal:  Vaccines (Basel)       Date:  2021-04-27

3.  Draft genomes of Shigella strains used by the STOPENTERICS consortium.

Authors:  Omar Rossi; Kate S Baker; Armelle Phalipon; François-Xavier Weill; Francesco Citiulo; Philippe Sansonetti; Christiane Gerke; Nicholas R Thomson
Journal:  Gut Pathog       Date:  2015-06-04       Impact factor: 4.181

4.  Deciphering minimal antigenic epitopes associated with Burkholderia pseudomallei and Burkholderia mallei lipopolysaccharide O-antigens.

Authors:  Marielle Tamigney Kenfack; Marcelina Mazur; Teerapat Nualnoi; Teresa L Shaffer; Abba Ngassimou; Yves Blériot; Jérôme Marrot; Roberta Marchetti; Kitisak Sintiprungrat; Narisara Chantratita; Alba Silipo; Antonio Molinaro; David P AuCoin; Mary N Burtnick; Paul J Brett; Charles Gauthier
Journal:  Nat Commun       Date:  2017-07-24       Impact factor: 14.919

5.  Bacteriophage Sf6 Tailspike Protein for Detection of Shigella flexneri Pathogens.

Authors:  Sonja Kunstmann; Tom Scheidt; Saskia Buchwald; Alexandra Helm; Laurence A Mulard; Angelika Fruth; Stefanie Barbirz
Journal:  Viruses       Date:  2018-08-15       Impact factor: 5.048

6.  Characterization and immunogenicity of a Shigella flexneri 2a O-antigen bioconjugate vaccine candidate.

Authors:  Neil Ravenscroft; Martin Braun; Joerg Schneider; Anita M Dreyer; Michael Wetter; Micha A Haeuptle; Stefan Kemmler; Michael Steffen; Dominique Sirena; Stefan Herwig; Paula Carranza; Claire Jones; Andrew J Pollard; Michael Wacker; Michael Kowarik
Journal:  Glycobiology       Date:  2019-08-20       Impact factor: 4.313

7.  The First-in-Human Synthetic Glycan-Based Conjugate Vaccine Candidate against Shigella.

Authors:  Robert M F van der Put; Carolien Smitsman; Alex de Haan; Martin Hamzink; Hans Timmermans; Joost Uittenbogaard; Janny Westdijk; Michiel Stork; Olga Ophorst; Françoise Thouron; Catherine Guerreiro; Philippe J Sansonetti; Armelle Phalipon; Laurence A Mulard
Journal:  ACS Cent Sci       Date:  2022-03-17       Impact factor: 18.728

Review 8.  Potential targets for next generation antimicrobial glycoconjugate vaccines.

Authors:  Francesca Micoli; Paolo Costantino; Roberto Adamo
Journal:  FEMS Microbiol Rev       Date:  2018-05-01       Impact factor: 16.408

9.  Structural characterisation of the capsular polysaccharide expressed by Burkholderia thailandensis strain E555:: wbiI (pKnock-KmR) and assessment of the significance of the 2-O-acetyl group in immune protection.

Authors:  Marc Bayliss; Matthew I Donaldson; Sergey A Nepogodiev; Giulia Pergolizzi; Andrew E Scott; Nicholas J Harmer; Robert A Field; Joann L Prior
Journal:  Carbohydr Res       Date:  2017-09-21       Impact factor: 2.975

Review 10.  Recent Advances in the Synthesis of Glycoconjugates for Vaccine Development.

Authors:  Cinzia Colombo; Olimpia Pitirollo; Luigi Lay
Journal:  Molecules       Date:  2018-07-13       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.